Laxatives for chronic constipation in adults

BMJ (Online)

Volumn 345, Issue 7883, 2012, Pages

  Ford, Alexander C ^a,b   Talley, Nicholas J ^c  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BISACODYL; DOCUSATE SODIUM; ISPAGULA; LACTULOSE; LAXATIVE; MACROGOL; MACROGOL 3350; PICOSULFATE SODIUM; PLACEBO;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CASE REPORT; CHRONIC DISEASE; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; FEMALE; FLATULENCE; HUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ALPROSTADIL; CONSTIPATION; FEMALE; HUMANS; LAXATIVES; MALE; META-ANALYSIS AS TOPIC; PEPTIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84869161572     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e6168     Document Type: Article

References (13)

1. World Gastroenterology Organisation. WGO practice guidelines: constipation. 2007. www.worldgastroenterology.org/assets/downloads/en/pdf/ guidelines/05-constipation.pdf
2. Brandt LJ, Chey WD, Foxx-Orenstein AE, Quigley EMM, Schiller LR, Schoenfeld PS, et al. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(suppl I):S8-35.
3. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011;106:1582-91.
4. Choung RS, Locke GR, III, Rey E, Schleck CD, Baum C, Zinsmeister AR, et al. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol 2012;10:494-500.
5. Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol 2009;7:9-19.
6. Chang JY, Locke III GR, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 2010;105:822-32.
7. Locke GR, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterology 2000;119:1766-78. (Pubitemid 32198703)
8. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005;100:936-71. (Pubitemid 40592390)
9. Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011;33:895-901.
10. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011;60:209-18.
11. Lee-Robichaud, Thomas K, Morgan J, Nelson RL. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 2010;7(7):CD007570.
12. Taylor RR, Guest JF. The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK. Aliment Pharmacol Ther 2010;15:302-12.
13. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol 2008;103:820-2. (Pubitemid 351501124)